Global Antibody-radionuclide Conjugates Market Research Report 2026(Status and Outlook)
Antibody-radionuclide Conjugates is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.The Antibody-radionuclide Conjugates Market is driven by the increasing interest in targeted cancer therapy and the potential of combining monoclonal antibodies with radioactive isotopes to deliver precise treatment. Antibody-radionuclide conjugates offer a highly focused approach to treating cancer by delivering radiation directly to tumor cells, minimizing damage to healthy tissue. As the understanding of cancer biology and immunotherapy advances, and personalized treatment options gain prominence, the demand for these conjugates continues to grow. Innovations in conjugation techniques, radiolabeling methods, and the expansion of the oncology pipeline further contribute to market expansion. However, a significant challenge for this market is the need to address complex drug development processes, optimize safety and efficacy, and navigate regulatory standards while ensuring affordability and accessibility for patients. Overcoming production challenges, minimizing off-target effects, and managing development costs are ongoing hurdles. Additionally, the market faces competition from other cancer therapies and the need for continuous research and development to enhance the efficiency and precision of antibody-radionuclide conjugates. Striking a balance between providing safe, effective, and accessible targeted cancer treatments while addressing scientific and regulatory challenges is essential for the continued growth of the Antibody-radionuclide Conjugates Market.
The global Antibody-radionuclide Conjugates market size was estimated at USD 1975.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 17.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Antibody-radionuclide Conjugates market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Antibody-radionuclide Conjugates market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Antibody-radionuclide Conjugates market.
Global Antibody-radionuclide Conjugates Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Curium Pharmaceuticals
Gilead Sciences
Clarity Pharmaceuticals
Curasight
Nordic Nanovector
Philogen
RadioMedix
Telix Pharmaceuticals
Orano Med
Actinium Pharmaceuticals
Y-mAbs Therapeutics
Fusion Pharmaceuticals
Market Segmentation (by Type)
Beta-emitting
Targeted Alpha Therapy
Market Segmentation (by Application)
Solid Tumor
Non Hodgkin Lymphoma
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Antibody-radionuclide Conjugates Market
Overview of the regional outlook of the Antibody-radionuclide Conjugates Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antibody-radionuclide Conjugates Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antibody-radionuclide Conjugates, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Antibody-radionuclide Conjugates market size was estimated at USD 1975.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 17.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Antibody-radionuclide Conjugates market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Antibody-radionuclide Conjugates market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Antibody-radionuclide Conjugates market.
Global Antibody-radionuclide Conjugates Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Curium Pharmaceuticals
Gilead Sciences
Clarity Pharmaceuticals
Curasight
Nordic Nanovector
Philogen
RadioMedix
Telix Pharmaceuticals
Orano Med
Actinium Pharmaceuticals
Y-mAbs Therapeutics
Fusion Pharmaceuticals
Market Segmentation (by Type)
Beta-emitting
Targeted Alpha Therapy
Market Segmentation (by Application)
Solid Tumor
Non Hodgkin Lymphoma
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Antibody-radionuclide Conjugates Market
Overview of the regional outlook of the Antibody-radionuclide Conjugates Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antibody-radionuclide Conjugates Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antibody-radionuclide Conjugates, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Antibody-radionuclide Conjugates
1.2 Key Market Segments
1.2.1 Antibody-radionuclide Conjugates Segment by Type
1.2.2 Antibody-radionuclide Conjugates Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antibody-radionuclide Conjugates Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Antibody-radionuclide Conjugates Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Antibody-radionuclide Conjugates Product Life Cycle
3.3 Global Antibody-radionuclide Conjugates Sales by Manufacturers (2020-2025)
3.4 Global Antibody-radionuclide Conjugates Revenue Market Share by Manufacturers (2020-2025)
3.5 Antibody-radionuclide Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Antibody-radionuclide Conjugates Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Antibody-radionuclide Conjugates Market Competitive Situation and Trends
3.8.1 Antibody-radionuclide Conjugates Market Concentration Rate
3.8.2 Global 5 and 10 Largest Antibody-radionuclide Conjugates Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ANTIBODY-RADIONUCLIDE CONJUGATES INDUSTRY CHAIN ANALYSIS
4.1 Antibody-radionuclide Conjugates Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIBODY-RADIONUCLIDE CONJUGATES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Antibody-radionuclide Conjugates Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Antibody-radionuclide Conjugates Market
5.7 ESG Ratings of Leading Companies
6 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antibody-radionuclide Conjugates Sales Market Share by Type (2020-2025)
6.3 Global Antibody-radionuclide Conjugates Market Size by Type (2020-2025)
6.4 Global Antibody-radionuclide Conjugates Price by Type (2020-2025)
7 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antibody-radionuclide Conjugates Market Sales by Application (2020-2025)
7.3 Global Antibody-radionuclide Conjugates Market Size (M USD) by Application (2020-2025)
7.4 Global Antibody-radionuclide Conjugates Sales Growth Rate by Application (2020-2025)
8 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET SALES BY REGION
8.1 Global Antibody-radionuclide Conjugates Sales by Region
8.1.1 Global Antibody-radionuclide Conjugates Sales by Region
8.1.2 Global Antibody-radionuclide Conjugates Sales Market Share by Region
8.2 Global Antibody-radionuclide Conjugates Market Size by Region
8.2.1 Global Antibody-radionuclide Conjugates Market Size by Region
8.2.2 Global Antibody-radionuclide Conjugates Market Size by Region
8.3 North America
8.3.1 North America Antibody-radionuclide Conjugates Sales by Country
8.3.2 North America Antibody-radionuclide Conjugates Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Antibody-radionuclide Conjugates Sales by Country
8.4.2 Europe Antibody-radionuclide Conjugates Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Antibody-radionuclide Conjugates Sales by Region
8.5.2 Asia Pacific Antibody-radionuclide Conjugates Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Antibody-radionuclide Conjugates Sales by Country
8.6.2 South America Antibody-radionuclide Conjugates Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Antibody-radionuclide Conjugates Sales by Region
8.7.2 Middle East and Africa Antibody-radionuclide Conjugates Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET PRODUCTION BY REGION
9.1 Global Production of Antibody-radionuclide Conjugates by Region(2020-2025)
9.2 Global Antibody-radionuclide Conjugates Revenue Market Share by Region (2020-2025)
9.3 Global Antibody-radionuclide Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Antibody-radionuclide Conjugates Production
9.4.1 North America Antibody-radionuclide Conjugates Production Growth Rate (2020-2025)
9.4.2 North America Antibody-radionuclide Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Antibody-radionuclide Conjugates Production
9.5.1 Europe Antibody-radionuclide Conjugates Production Growth Rate (2020-2025)
9.5.2 Europe Antibody-radionuclide Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Antibody-radionuclide Conjugates Production (2020-2025)
9.6.1 Japan Antibody-radionuclide Conjugates Production Growth Rate (2020-2025)
9.6.2 Japan Antibody-radionuclide Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Antibody-radionuclide Conjugates Production (2020-2025)
9.7.1 China Antibody-radionuclide Conjugates Production Growth Rate (2020-2025)
9.7.2 China Antibody-radionuclide Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer
10.1.1 Bayer Basic Information
10.1.2 Bayer Antibody-radionuclide Conjugates Product Overview
10.1.3 Bayer Antibody-radionuclide Conjugates Product Market Performance
10.1.4 Bayer Business Overview
10.1.5 Bayer SWOT Analysis
10.1.6 Bayer Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Antibody-radionuclide Conjugates Product Overview
10.2.3 Novartis Antibody-radionuclide Conjugates Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Lantheus
10.3.1 Lantheus Basic Information
10.3.2 Lantheus Antibody-radionuclide Conjugates Product Overview
10.3.3 Lantheus Antibody-radionuclide Conjugates Product Market Performance
10.3.4 Lantheus Business Overview
10.3.5 Lantheus SWOT Analysis
10.3.6 Lantheus Recent Developments
10.4 Aurobindo Pharma
10.4.1 Aurobindo Pharma Basic Information
10.4.2 Aurobindo Pharma Antibody-radionuclide Conjugates Product Overview
10.4.3 Aurobindo Pharma Antibody-radionuclide Conjugates Product Market Performance
10.4.4 Aurobindo Pharma Business Overview
10.4.5 Aurobindo Pharma Recent Developments
10.5 Mundipharma
10.5.1 Mundipharma Basic Information
10.5.2 Mundipharma Antibody-radionuclide Conjugates Product Overview
10.5.3 Mundipharma Antibody-radionuclide Conjugates Product Market Performance
10.5.4 Mundipharma Business Overview
10.5.5 Mundipharma Recent Developments
10.6 China Isotope and Radiation
10.6.1 China Isotope and Radiation Basic Information
10.6.2 China Isotope and Radiation Antibody-radionuclide Conjugates Product Overview
10.6.3 China Isotope and Radiation Antibody-radionuclide Conjugates Product Market Performance
10.6.4 China Isotope and Radiation Business Overview
10.6.5 China Isotope and Radiation Recent Developments
10.7 Curium Pharmaceuticals
10.7.1 Curium Pharmaceuticals Basic Information
10.7.2 Curium Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
10.7.3 Curium Pharmaceuticals Antibody-radionuclide Conjugates Product Market Performance
10.7.4 Curium Pharmaceuticals Business Overview
10.7.5 Curium Pharmaceuticals Recent Developments
10.8 Gilead Sciences
10.8.1 Gilead Sciences Basic Information
10.8.2 Gilead Sciences Antibody-radionuclide Conjugates Product Overview
10.8.3 Gilead Sciences Antibody-radionuclide Conjugates Product Market Performance
10.8.4 Gilead Sciences Business Overview
10.8.5 Gilead Sciences Recent Developments
10.9 Clarity Pharmaceuticals
10.9.1 Clarity Pharmaceuticals Basic Information
10.9.2 Clarity Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
10.9.3 Clarity Pharmaceuticals Antibody-radionuclide Conjugates Product Market Performance
10.9.4 Clarity Pharmaceuticals Business Overview
10.9.5 Clarity Pharmaceuticals Recent Developments
10.10 Curasight
10.10.1 Curasight Basic Information
10.10.2 Curasight Antibody-radionuclide Conjugates Product Overview
10.10.3 Curasight Antibody-radionuclide Conjugates Product Market Performance
10.10.4 Curasight Business Overview
10.10.5 Curasight Recent Developments
10.11 Nordic Nanovector
10.11.1 Nordic Nanovector Basic Information
10.11.2 Nordic Nanovector Antibody-radionuclide Conjugates Product Overview
10.11.3 Nordic Nanovector Antibody-radionuclide Conjugates Product Market Performance
10.11.4 Nordic Nanovector Business Overview
10.11.5 Nordic Nanovector Recent Developments
10.12 Philogen
10.12.1 Philogen Basic Information
10.12.2 Philogen Antibody-radionuclide Conjugates Product Overview
10.12.3 Philogen Antibody-radionuclide Conjugates Product Market Performance
10.12.4 Philogen Business Overview
10.12.5 Philogen Recent Developments
10.13 RadioMedix
10.13.1 RadioMedix Basic Information
10.13.2 RadioMedix Antibody-radionuclide Conjugates Product Overview
10.13.3 RadioMedix Antibody-radionuclide Conjugates Product Market Performance
10.13.4 RadioMedix Business Overview
10.13.5 RadioMedix Recent Developments
10.14 Telix Pharmaceuticals
10.14.1 Telix Pharmaceuticals Basic Information
10.14.2 Telix Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
10.14.3 Telix Pharmaceuticals Antibody-radionuclide Conjugates Product Market Performance
10.14.4 Telix Pharmaceuticals Business Overview
10.14.5 Telix Pharmaceuticals Recent Developments
10.15 Orano Med
10.15.1 Orano Med Basic Information
10.15.2 Orano Med Antibody-radionuclide Conjugates Product Overview
10.15.3 Orano Med Antibody-radionuclide Conjugates Product Market Performance
10.15.4 Orano Med Business Overview
10.15.5 Orano Med Recent Developments
10.16 Actinium Pharmaceuticals
10.16.1 Actinium Pharmaceuticals Basic Information
10.16.2 Actinium Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
10.16.3 Actinium Pharmaceuticals Antibody-radionuclide Conjugates Product Market Performance
10.16.4 Actinium Pharmaceuticals Business Overview
10.16.5 Actinium Pharmaceuticals Recent Developments
10.17 Y-mAbs Therapeutics
10.17.1 Y-mAbs Therapeutics Basic Information
10.17.2 Y-mAbs Therapeutics Antibody-radionuclide Conjugates Product Overview
10.17.3 Y-mAbs Therapeutics Antibody-radionuclide Conjugates Product Market Performance
10.17.4 Y-mAbs Therapeutics Business Overview
10.17.5 Y-mAbs Therapeutics Recent Developments
10.18 Fusion Pharmaceuticals
10.18.1 Fusion Pharmaceuticals Basic Information
10.18.2 Fusion Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
10.18.3 Fusion Pharmaceuticals Antibody-radionuclide Conjugates Product Market Performance
10.18.4 Fusion Pharmaceuticals Business Overview
10.18.5 Fusion Pharmaceuticals Recent Developments
11 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET FORECAST BY REGION
11.1 Global Antibody-radionuclide Conjugates Market Size Forecast
11.2 Global Antibody-radionuclide Conjugates Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Antibody-radionuclide Conjugates Market Size Forecast by Country
11.2.3 Asia Pacific Antibody-radionuclide Conjugates Market Size Forecast by Region
11.2.4 South America Antibody-radionuclide Conjugates Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Antibody-radionuclide Conjugates by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Antibody-radionuclide Conjugates Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Antibody-radionuclide Conjugates by Type (2026-2035)
12.1.2 Global Antibody-radionuclide Conjugates Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Antibody-radionuclide Conjugates by Type (2026-2035)
12.2 Global Antibody-radionuclide Conjugates Market Forecast by Application (2026-2035)
12.2.1 Global Antibody-radionuclide Conjugates Sales (K MT) Forecast by Application
12.2.2 Global Antibody-radionuclide Conjugates Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Antibody-radionuclide Conjugates
1.2 Key Market Segments
1.2.1 Antibody-radionuclide Conjugates Segment by Type
1.2.2 Antibody-radionuclide Conjugates Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antibody-radionuclide Conjugates Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Antibody-radionuclide Conjugates Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Antibody-radionuclide Conjugates Product Life Cycle
3.3 Global Antibody-radionuclide Conjugates Sales by Manufacturers (2020-2025)
3.4 Global Antibody-radionuclide Conjugates Revenue Market Share by Manufacturers (2020-2025)
3.5 Antibody-radionuclide Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Antibody-radionuclide Conjugates Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Antibody-radionuclide Conjugates Market Competitive Situation and Trends
3.8.1 Antibody-radionuclide Conjugates Market Concentration Rate
3.8.2 Global 5 and 10 Largest Antibody-radionuclide Conjugates Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ANTIBODY-RADIONUCLIDE CONJUGATES INDUSTRY CHAIN ANALYSIS
4.1 Antibody-radionuclide Conjugates Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIBODY-RADIONUCLIDE CONJUGATES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Antibody-radionuclide Conjugates Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Antibody-radionuclide Conjugates Market
5.7 ESG Ratings of Leading Companies
6 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antibody-radionuclide Conjugates Sales Market Share by Type (2020-2025)
6.3 Global Antibody-radionuclide Conjugates Market Size by Type (2020-2025)
6.4 Global Antibody-radionuclide Conjugates Price by Type (2020-2025)
7 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antibody-radionuclide Conjugates Market Sales by Application (2020-2025)
7.3 Global Antibody-radionuclide Conjugates Market Size (M USD) by Application (2020-2025)
7.4 Global Antibody-radionuclide Conjugates Sales Growth Rate by Application (2020-2025)
8 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET SALES BY REGION
8.1 Global Antibody-radionuclide Conjugates Sales by Region
8.1.1 Global Antibody-radionuclide Conjugates Sales by Region
8.1.2 Global Antibody-radionuclide Conjugates Sales Market Share by Region
8.2 Global Antibody-radionuclide Conjugates Market Size by Region
8.2.1 Global Antibody-radionuclide Conjugates Market Size by Region
8.2.2 Global Antibody-radionuclide Conjugates Market Size by Region
8.3 North America
8.3.1 North America Antibody-radionuclide Conjugates Sales by Country
8.3.2 North America Antibody-radionuclide Conjugates Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Antibody-radionuclide Conjugates Sales by Country
8.4.2 Europe Antibody-radionuclide Conjugates Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Antibody-radionuclide Conjugates Sales by Region
8.5.2 Asia Pacific Antibody-radionuclide Conjugates Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Antibody-radionuclide Conjugates Sales by Country
8.6.2 South America Antibody-radionuclide Conjugates Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Antibody-radionuclide Conjugates Sales by Region
8.7.2 Middle East and Africa Antibody-radionuclide Conjugates Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET PRODUCTION BY REGION
9.1 Global Production of Antibody-radionuclide Conjugates by Region(2020-2025)
9.2 Global Antibody-radionuclide Conjugates Revenue Market Share by Region (2020-2025)
9.3 Global Antibody-radionuclide Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Antibody-radionuclide Conjugates Production
9.4.1 North America Antibody-radionuclide Conjugates Production Growth Rate (2020-2025)
9.4.2 North America Antibody-radionuclide Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Antibody-radionuclide Conjugates Production
9.5.1 Europe Antibody-radionuclide Conjugates Production Growth Rate (2020-2025)
9.5.2 Europe Antibody-radionuclide Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Antibody-radionuclide Conjugates Production (2020-2025)
9.6.1 Japan Antibody-radionuclide Conjugates Production Growth Rate (2020-2025)
9.6.2 Japan Antibody-radionuclide Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Antibody-radionuclide Conjugates Production (2020-2025)
9.7.1 China Antibody-radionuclide Conjugates Production Growth Rate (2020-2025)
9.7.2 China Antibody-radionuclide Conjugates Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer
10.1.1 Bayer Basic Information
10.1.2 Bayer Antibody-radionuclide Conjugates Product Overview
10.1.3 Bayer Antibody-radionuclide Conjugates Product Market Performance
10.1.4 Bayer Business Overview
10.1.5 Bayer SWOT Analysis
10.1.6 Bayer Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Antibody-radionuclide Conjugates Product Overview
10.2.3 Novartis Antibody-radionuclide Conjugates Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Lantheus
10.3.1 Lantheus Basic Information
10.3.2 Lantheus Antibody-radionuclide Conjugates Product Overview
10.3.3 Lantheus Antibody-radionuclide Conjugates Product Market Performance
10.3.4 Lantheus Business Overview
10.3.5 Lantheus SWOT Analysis
10.3.6 Lantheus Recent Developments
10.4 Aurobindo Pharma
10.4.1 Aurobindo Pharma Basic Information
10.4.2 Aurobindo Pharma Antibody-radionuclide Conjugates Product Overview
10.4.3 Aurobindo Pharma Antibody-radionuclide Conjugates Product Market Performance
10.4.4 Aurobindo Pharma Business Overview
10.4.5 Aurobindo Pharma Recent Developments
10.5 Mundipharma
10.5.1 Mundipharma Basic Information
10.5.2 Mundipharma Antibody-radionuclide Conjugates Product Overview
10.5.3 Mundipharma Antibody-radionuclide Conjugates Product Market Performance
10.5.4 Mundipharma Business Overview
10.5.5 Mundipharma Recent Developments
10.6 China Isotope and Radiation
10.6.1 China Isotope and Radiation Basic Information
10.6.2 China Isotope and Radiation Antibody-radionuclide Conjugates Product Overview
10.6.3 China Isotope and Radiation Antibody-radionuclide Conjugates Product Market Performance
10.6.4 China Isotope and Radiation Business Overview
10.6.5 China Isotope and Radiation Recent Developments
10.7 Curium Pharmaceuticals
10.7.1 Curium Pharmaceuticals Basic Information
10.7.2 Curium Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
10.7.3 Curium Pharmaceuticals Antibody-radionuclide Conjugates Product Market Performance
10.7.4 Curium Pharmaceuticals Business Overview
10.7.5 Curium Pharmaceuticals Recent Developments
10.8 Gilead Sciences
10.8.1 Gilead Sciences Basic Information
10.8.2 Gilead Sciences Antibody-radionuclide Conjugates Product Overview
10.8.3 Gilead Sciences Antibody-radionuclide Conjugates Product Market Performance
10.8.4 Gilead Sciences Business Overview
10.8.5 Gilead Sciences Recent Developments
10.9 Clarity Pharmaceuticals
10.9.1 Clarity Pharmaceuticals Basic Information
10.9.2 Clarity Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
10.9.3 Clarity Pharmaceuticals Antibody-radionuclide Conjugates Product Market Performance
10.9.4 Clarity Pharmaceuticals Business Overview
10.9.5 Clarity Pharmaceuticals Recent Developments
10.10 Curasight
10.10.1 Curasight Basic Information
10.10.2 Curasight Antibody-radionuclide Conjugates Product Overview
10.10.3 Curasight Antibody-radionuclide Conjugates Product Market Performance
10.10.4 Curasight Business Overview
10.10.5 Curasight Recent Developments
10.11 Nordic Nanovector
10.11.1 Nordic Nanovector Basic Information
10.11.2 Nordic Nanovector Antibody-radionuclide Conjugates Product Overview
10.11.3 Nordic Nanovector Antibody-radionuclide Conjugates Product Market Performance
10.11.4 Nordic Nanovector Business Overview
10.11.5 Nordic Nanovector Recent Developments
10.12 Philogen
10.12.1 Philogen Basic Information
10.12.2 Philogen Antibody-radionuclide Conjugates Product Overview
10.12.3 Philogen Antibody-radionuclide Conjugates Product Market Performance
10.12.4 Philogen Business Overview
10.12.5 Philogen Recent Developments
10.13 RadioMedix
10.13.1 RadioMedix Basic Information
10.13.2 RadioMedix Antibody-radionuclide Conjugates Product Overview
10.13.3 RadioMedix Antibody-radionuclide Conjugates Product Market Performance
10.13.4 RadioMedix Business Overview
10.13.5 RadioMedix Recent Developments
10.14 Telix Pharmaceuticals
10.14.1 Telix Pharmaceuticals Basic Information
10.14.2 Telix Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
10.14.3 Telix Pharmaceuticals Antibody-radionuclide Conjugates Product Market Performance
10.14.4 Telix Pharmaceuticals Business Overview
10.14.5 Telix Pharmaceuticals Recent Developments
10.15 Orano Med
10.15.1 Orano Med Basic Information
10.15.2 Orano Med Antibody-radionuclide Conjugates Product Overview
10.15.3 Orano Med Antibody-radionuclide Conjugates Product Market Performance
10.15.4 Orano Med Business Overview
10.15.5 Orano Med Recent Developments
10.16 Actinium Pharmaceuticals
10.16.1 Actinium Pharmaceuticals Basic Information
10.16.2 Actinium Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
10.16.3 Actinium Pharmaceuticals Antibody-radionuclide Conjugates Product Market Performance
10.16.4 Actinium Pharmaceuticals Business Overview
10.16.5 Actinium Pharmaceuticals Recent Developments
10.17 Y-mAbs Therapeutics
10.17.1 Y-mAbs Therapeutics Basic Information
10.17.2 Y-mAbs Therapeutics Antibody-radionuclide Conjugates Product Overview
10.17.3 Y-mAbs Therapeutics Antibody-radionuclide Conjugates Product Market Performance
10.17.4 Y-mAbs Therapeutics Business Overview
10.17.5 Y-mAbs Therapeutics Recent Developments
10.18 Fusion Pharmaceuticals
10.18.1 Fusion Pharmaceuticals Basic Information
10.18.2 Fusion Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
10.18.3 Fusion Pharmaceuticals Antibody-radionuclide Conjugates Product Market Performance
10.18.4 Fusion Pharmaceuticals Business Overview
10.18.5 Fusion Pharmaceuticals Recent Developments
11 ANTIBODY-RADIONUCLIDE CONJUGATES MARKET FORECAST BY REGION
11.1 Global Antibody-radionuclide Conjugates Market Size Forecast
11.2 Global Antibody-radionuclide Conjugates Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Antibody-radionuclide Conjugates Market Size Forecast by Country
11.2.3 Asia Pacific Antibody-radionuclide Conjugates Market Size Forecast by Region
11.2.4 South America Antibody-radionuclide Conjugates Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Antibody-radionuclide Conjugates by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Antibody-radionuclide Conjugates Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Antibody-radionuclide Conjugates by Type (2026-2035)
12.1.2 Global Antibody-radionuclide Conjugates Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Antibody-radionuclide Conjugates by Type (2026-2035)
12.2 Global Antibody-radionuclide Conjugates Market Forecast by Application (2026-2035)
12.2.1 Global Antibody-radionuclide Conjugates Sales (K MT) Forecast by Application
12.2.2 Global Antibody-radionuclide Conjugates Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Antibody-radionuclide Conjugates Market Size by Type (M USD)
Table 4. Global Antibody-radionuclide Conjugates Market Size by Application
Table 5. Antibody-radionuclide Conjugates Market Size Comparison by Region (M USD)
Table 6. Global Antibody-radionuclide Conjugates Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Antibody-radionuclide Conjugates Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Antibody-radionuclide Conjugates Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Antibody-radionuclide Conjugates Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-radionuclide Conjugates as of 2025)
Table 11. Global Market Antibody-radionuclide Conjugates Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Antibody-radionuclide Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antibody-radionuclide Conjugates Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Antibody-radionuclide Conjugates Sales by Type (K MT)
Table 27. Global Antibody-radionuclide Conjugates Market Size by Type (M USD)
Table 28. Global Antibody-radionuclide Conjugates Sales (K MT) by Type (2020-2025)
Table 29. Global Antibody-radionuclide Conjugates Sales Market Share by Type (2020-2025)
Table 30. Global Antibody-radionuclide Conjugates Market Size (M USD) by Type (2020-2025)
Table 31. Global Antibody-radionuclide Conjugates Market Share by Type (2020-2025)
Table 32. Global Antibody-radionuclide Conjugates Price (USD/KG) by Type (2020-2025)
Table 33. Global Antibody-radionuclide Conjugates Sales (K MT) by Application
Table 34. Global Antibody-radionuclide Conjugates Market Size by Application
Table 35. Global Antibody-radionuclide Conjugates Sales by Application (2020-2025) & (K MT)
Table 36. Global Antibody-radionuclide Conjugates Sales Market Share by Application (2020-2025)
Table 37. Global Antibody-radionuclide Conjugates Market Size by Application (2020-2025) & (M USD)
Table 38. Global Antibody-radionuclide Conjugates Market Share by Application (2020-2025)
Table 39. Global Antibody-radionuclide Conjugates Sales Growth Rate by Application (2020-2025)
Table 40. Global Antibody-radionuclide Conjugates Sales by Region (2020-2025) & (K MT)
Table 41. Global Antibody-radionuclide Conjugates Sales Market Share by Region (2020-2025)
Table 42. Global Antibody-radionuclide Conjugates Market Size by Region (2020-2025) & (M USD)
Table 43. Global Antibody-radionuclide Conjugates Market Size by Region (2020-2025)
Table 44. North America Antibody-radionuclide Conjugates Sales by Country (2020-2025) & (K MT)
Table 45. North America Antibody-radionuclide Conjugates Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Antibody-radionuclide Conjugates Sales by Country (2020-2025) & (K MT)
Table 47. Europe Antibody-radionuclide Conjugates Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Antibody-radionuclide Conjugates Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Antibody-radionuclide Conjugates Market Size by Region (2020-2025) & (M USD)
Table 50. South America Antibody-radionuclide Conjugates Sales by Country (2020-2025) & (K MT)
Table 51. South America Antibody-radionuclide Conjugates Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Antibody-radionuclide Conjugates Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Antibody-radionuclide Conjugates Market Size by Region (2020-2025) & (M USD)
Table 54. Global Antibody-radionuclide Conjugates Production (K MT) by Region(2020-2025)
Table 55. Global Antibody-radionuclide Conjugates Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Antibody-radionuclide Conjugates Revenue Market Share by Region (2020-2025)
Table 57. Global Antibody-radionuclide Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Antibody-radionuclide Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Antibody-radionuclide Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Antibody-radionuclide Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Antibody-radionuclide Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bayer Basic Information
Table 63. Bayer Antibody-radionuclide Conjugates Product Overview
Table 64. Bayer Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bayer Business Overview
Table 66. Bayer SWOT Analysis
Table 67. Bayer Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis Antibody-radionuclide Conjugates Product Overview
Table 70. Novartis Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Lantheus Basic Information
Table 75. Lantheus Antibody-radionuclide Conjugates Product Overview
Table 76. Lantheus Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Lantheus Business Overview
Table 78. Lantheus SWOT Analysis
Table 79. Lantheus Recent Developments
Table 80. Aurobindo Pharma Basic Information
Table 81. Aurobindo Pharma Antibody-radionuclide Conjugates Product Overview
Table 82. Aurobindo Pharma Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Aurobindo Pharma Business Overview
Table 84. Aurobindo Pharma Recent Developments
Table 85. Mundipharma Basic Information
Table 86. Mundipharma Antibody-radionuclide Conjugates Product Overview
Table 87. Mundipharma Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Mundipharma Business Overview
Table 89. Mundipharma Recent Developments
Table 90. China Isotope and Radiation Basic Information
Table 91. China Isotope and Radiation Antibody-radionuclide Conjugates Product Overview
Table 92. China Isotope and Radiation Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. China Isotope and Radiation Business Overview
Table 94. China Isotope and Radiation Recent Developments
Table 95. Curium Pharmaceuticals Basic Information
Table 96. Curium Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
Table 97. Curium Pharmaceuticals Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Curium Pharmaceuticals Business Overview
Table 99. Curium Pharmaceuticals Recent Developments
Table 100. Gilead Sciences Basic Information
Table 101. Gilead Sciences Antibody-radionuclide Conjugates Product Overview
Table 102. Gilead Sciences Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Gilead Sciences Business Overview
Table 104. Gilead Sciences Recent Developments
Table 105. Clarity Pharmaceuticals Basic Information
Table 106. Clarity Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
Table 107. Clarity Pharmaceuticals Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Clarity Pharmaceuticals Business Overview
Table 109. Clarity Pharmaceuticals Recent Developments
Table 110. Curasight Basic Information
Table 111. Curasight Antibody-radionuclide Conjugates Product Overview
Table 112. Curasight Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Curasight Business Overview
Table 114. Curasight Recent Developments
Table 115. Nordic Nanovector Basic Information
Table 116. Nordic Nanovector Antibody-radionuclide Conjugates Product Overview
Table 117. Nordic Nanovector Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Nordic Nanovector Business Overview
Table 119. Nordic Nanovector Recent Developments
Table 120. Philogen Basic Information
Table 121. Philogen Antibody-radionuclide Conjugates Product Overview
Table 122. Philogen Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Philogen Business Overview
Table 124. Philogen Recent Developments
Table 125. RadioMedix Basic Information
Table 126. RadioMedix Antibody-radionuclide Conjugates Product Overview
Table 127. RadioMedix Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. RadioMedix Business Overview
Table 129. RadioMedix Recent Developments
Table 130. Telix Pharmaceuticals Basic Information
Table 131. Telix Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
Table 132. Telix Pharmaceuticals Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Telix Pharmaceuticals Business Overview
Table 134. Telix Pharmaceuticals Recent Developments
Table 135. Orano Med Basic Information
Table 136. Orano Med Antibody-radionuclide Conjugates Product Overview
Table 137. Orano Med Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Orano Med Business Overview
Table 139. Orano Med Recent Developments
Table 140. Actinium Pharmaceuticals Basic Information
Table 141. Actinium Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
Table 142. Actinium Pharmaceuticals Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Actinium Pharmaceuticals Business Overview
Table 144. Actinium Pharmaceuticals Recent Developments
Table 145. Y-mAbs Therapeutics Basic Information
Table 146. Y-mAbs Therapeutics Antibody-radionuclide Conjugates Product Overview
Table 147. Y-mAbs Therapeutics Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Y-mAbs Therapeutics Business Overview
Table 149. Y-mAbs Therapeutics Recent Developments
Table 150. Fusion Pharmaceuticals Basic Information
Table 151. Fusion Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
Table 152. Fusion Pharmaceuticals Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Fusion Pharmaceuticals Business Overview
Table 154. Fusion Pharmaceuticals Recent Developments
Table 155. Global Antibody-radionuclide Conjugates Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Antibody-radionuclide Conjugates Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Antibody-radionuclide Conjugates Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Antibody-radionuclide Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Antibody-radionuclide Conjugates Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Antibody-radionuclide Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Antibody-radionuclide Conjugates Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Antibody-radionuclide Conjugates Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Antibody-radionuclide Conjugates Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Antibody-radionuclide Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Antibody-radionuclide Conjugates Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Antibody-radionuclide Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Antibody-radionuclide Conjugates Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Antibody-radionuclide Conjugates Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Antibody-radionuclide Conjugates Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Antibody-radionuclide Conjugates Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Antibody-radionuclide Conjugates Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Antibody-radionuclide Conjugates Market Size by Type (M USD)
Table 4. Global Antibody-radionuclide Conjugates Market Size by Application
Table 5. Antibody-radionuclide Conjugates Market Size Comparison by Region (M USD)
Table 6. Global Antibody-radionuclide Conjugates Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Antibody-radionuclide Conjugates Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Antibody-radionuclide Conjugates Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Antibody-radionuclide Conjugates Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-radionuclide Conjugates as of 2025)
Table 11. Global Market Antibody-radionuclide Conjugates Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Antibody-radionuclide Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antibody-radionuclide Conjugates Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Antibody-radionuclide Conjugates Sales by Type (K MT)
Table 27. Global Antibody-radionuclide Conjugates Market Size by Type (M USD)
Table 28. Global Antibody-radionuclide Conjugates Sales (K MT) by Type (2020-2025)
Table 29. Global Antibody-radionuclide Conjugates Sales Market Share by Type (2020-2025)
Table 30. Global Antibody-radionuclide Conjugates Market Size (M USD) by Type (2020-2025)
Table 31. Global Antibody-radionuclide Conjugates Market Share by Type (2020-2025)
Table 32. Global Antibody-radionuclide Conjugates Price (USD/KG) by Type (2020-2025)
Table 33. Global Antibody-radionuclide Conjugates Sales (K MT) by Application
Table 34. Global Antibody-radionuclide Conjugates Market Size by Application
Table 35. Global Antibody-radionuclide Conjugates Sales by Application (2020-2025) & (K MT)
Table 36. Global Antibody-radionuclide Conjugates Sales Market Share by Application (2020-2025)
Table 37. Global Antibody-radionuclide Conjugates Market Size by Application (2020-2025) & (M USD)
Table 38. Global Antibody-radionuclide Conjugates Market Share by Application (2020-2025)
Table 39. Global Antibody-radionuclide Conjugates Sales Growth Rate by Application (2020-2025)
Table 40. Global Antibody-radionuclide Conjugates Sales by Region (2020-2025) & (K MT)
Table 41. Global Antibody-radionuclide Conjugates Sales Market Share by Region (2020-2025)
Table 42. Global Antibody-radionuclide Conjugates Market Size by Region (2020-2025) & (M USD)
Table 43. Global Antibody-radionuclide Conjugates Market Size by Region (2020-2025)
Table 44. North America Antibody-radionuclide Conjugates Sales by Country (2020-2025) & (K MT)
Table 45. North America Antibody-radionuclide Conjugates Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Antibody-radionuclide Conjugates Sales by Country (2020-2025) & (K MT)
Table 47. Europe Antibody-radionuclide Conjugates Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Antibody-radionuclide Conjugates Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Antibody-radionuclide Conjugates Market Size by Region (2020-2025) & (M USD)
Table 50. South America Antibody-radionuclide Conjugates Sales by Country (2020-2025) & (K MT)
Table 51. South America Antibody-radionuclide Conjugates Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Antibody-radionuclide Conjugates Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Antibody-radionuclide Conjugates Market Size by Region (2020-2025) & (M USD)
Table 54. Global Antibody-radionuclide Conjugates Production (K MT) by Region(2020-2025)
Table 55. Global Antibody-radionuclide Conjugates Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Antibody-radionuclide Conjugates Revenue Market Share by Region (2020-2025)
Table 57. Global Antibody-radionuclide Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Antibody-radionuclide Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Antibody-radionuclide Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Antibody-radionuclide Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Antibody-radionuclide Conjugates Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bayer Basic Information
Table 63. Bayer Antibody-radionuclide Conjugates Product Overview
Table 64. Bayer Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bayer Business Overview
Table 66. Bayer SWOT Analysis
Table 67. Bayer Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis Antibody-radionuclide Conjugates Product Overview
Table 70. Novartis Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Lantheus Basic Information
Table 75. Lantheus Antibody-radionuclide Conjugates Product Overview
Table 76. Lantheus Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Lantheus Business Overview
Table 78. Lantheus SWOT Analysis
Table 79. Lantheus Recent Developments
Table 80. Aurobindo Pharma Basic Information
Table 81. Aurobindo Pharma Antibody-radionuclide Conjugates Product Overview
Table 82. Aurobindo Pharma Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Aurobindo Pharma Business Overview
Table 84. Aurobindo Pharma Recent Developments
Table 85. Mundipharma Basic Information
Table 86. Mundipharma Antibody-radionuclide Conjugates Product Overview
Table 87. Mundipharma Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Mundipharma Business Overview
Table 89. Mundipharma Recent Developments
Table 90. China Isotope and Radiation Basic Information
Table 91. China Isotope and Radiation Antibody-radionuclide Conjugates Product Overview
Table 92. China Isotope and Radiation Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. China Isotope and Radiation Business Overview
Table 94. China Isotope and Radiation Recent Developments
Table 95. Curium Pharmaceuticals Basic Information
Table 96. Curium Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
Table 97. Curium Pharmaceuticals Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Curium Pharmaceuticals Business Overview
Table 99. Curium Pharmaceuticals Recent Developments
Table 100. Gilead Sciences Basic Information
Table 101. Gilead Sciences Antibody-radionuclide Conjugates Product Overview
Table 102. Gilead Sciences Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Gilead Sciences Business Overview
Table 104. Gilead Sciences Recent Developments
Table 105. Clarity Pharmaceuticals Basic Information
Table 106. Clarity Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
Table 107. Clarity Pharmaceuticals Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Clarity Pharmaceuticals Business Overview
Table 109. Clarity Pharmaceuticals Recent Developments
Table 110. Curasight Basic Information
Table 111. Curasight Antibody-radionuclide Conjugates Product Overview
Table 112. Curasight Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Curasight Business Overview
Table 114. Curasight Recent Developments
Table 115. Nordic Nanovector Basic Information
Table 116. Nordic Nanovector Antibody-radionuclide Conjugates Product Overview
Table 117. Nordic Nanovector Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Nordic Nanovector Business Overview
Table 119. Nordic Nanovector Recent Developments
Table 120. Philogen Basic Information
Table 121. Philogen Antibody-radionuclide Conjugates Product Overview
Table 122. Philogen Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Philogen Business Overview
Table 124. Philogen Recent Developments
Table 125. RadioMedix Basic Information
Table 126. RadioMedix Antibody-radionuclide Conjugates Product Overview
Table 127. RadioMedix Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. RadioMedix Business Overview
Table 129. RadioMedix Recent Developments
Table 130. Telix Pharmaceuticals Basic Information
Table 131. Telix Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
Table 132. Telix Pharmaceuticals Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Telix Pharmaceuticals Business Overview
Table 134. Telix Pharmaceuticals Recent Developments
Table 135. Orano Med Basic Information
Table 136. Orano Med Antibody-radionuclide Conjugates Product Overview
Table 137. Orano Med Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Orano Med Business Overview
Table 139. Orano Med Recent Developments
Table 140. Actinium Pharmaceuticals Basic Information
Table 141. Actinium Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
Table 142. Actinium Pharmaceuticals Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Actinium Pharmaceuticals Business Overview
Table 144. Actinium Pharmaceuticals Recent Developments
Table 145. Y-mAbs Therapeutics Basic Information
Table 146. Y-mAbs Therapeutics Antibody-radionuclide Conjugates Product Overview
Table 147. Y-mAbs Therapeutics Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Y-mAbs Therapeutics Business Overview
Table 149. Y-mAbs Therapeutics Recent Developments
Table 150. Fusion Pharmaceuticals Basic Information
Table 151. Fusion Pharmaceuticals Antibody-radionuclide Conjugates Product Overview
Table 152. Fusion Pharmaceuticals Antibody-radionuclide Conjugates Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Fusion Pharmaceuticals Business Overview
Table 154. Fusion Pharmaceuticals Recent Developments
Table 155. Global Antibody-radionuclide Conjugates Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Antibody-radionuclide Conjugates Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Antibody-radionuclide Conjugates Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Antibody-radionuclide Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Antibody-radionuclide Conjugates Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Antibody-radionuclide Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Antibody-radionuclide Conjugates Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Antibody-radionuclide Conjugates Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Antibody-radionuclide Conjugates Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Antibody-radionuclide Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Antibody-radionuclide Conjugates Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Antibody-radionuclide Conjugates Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Antibody-radionuclide Conjugates Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Antibody-radionuclide Conjugates Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Antibody-radionuclide Conjugates Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Antibody-radionuclide Conjugates Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Antibody-radionuclide Conjugates Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Antibody-radionuclide Conjugates
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antibody-radionuclide Conjugates Market Size (M USD), 2025-2035
Figure 5. Global Antibody-radionuclide Conjugates Market Size (M USD) (2020-2035)
Figure 6. Global Antibody-radionuclide Conjugates Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antibody-radionuclide Conjugates Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Antibody-radionuclide Conjugates Product Life Cycle
Figure 13. Antibody-radionuclide Conjugates Sales Share by Manufacturers in 2025
Figure 14. Global Antibody-radionuclide Conjugates Revenue Share by Manufacturers in 2025
Figure 15. Antibody-radionuclide Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Antibody-radionuclide Conjugates Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Antibody-radionuclide Conjugates Revenue in 2025
Figure 18. Industry Chain Map of Antibody-radionuclide Conjugates
Figure 19. Global Antibody-radionuclide Conjugates Market PEST Analysis
Figure 20. Global Antibody-radionuclide Conjugates Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Antibody-radionuclide Conjugates Market Share by Type
Figure 27. Sales Market Share of Antibody-radionuclide Conjugates by Type (2020-2025)
Figure 28. Sales Market Share of Antibody-radionuclide Conjugates by Type in 2025
Figure 29. Market Share of Antibody-radionuclide Conjugates by Type (2020-2025)
Figure 30. Market Share of Antibody-radionuclide Conjugates by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Antibody-radionuclide Conjugates Market Share by Application
Figure 33. Global Antibody-radionuclide Conjugates Sales Market Share by Application (2020-2025)
Figure 34. Global Antibody-radionuclide Conjugates Sales Market Share by Application in 2025
Figure 35. Global Antibody-radionuclide Conjugates Market Share by Application (2020-2025)
Figure 36. Global Antibody-radionuclide Conjugates Market Share by Application in 2025
Figure 37. Global Antibody-radionuclide Conjugates Sales Growth Rate by Application (2020-2025)
Figure 38. Global Antibody-radionuclide Conjugates Sales Market Share by Region (2020-2025)
Figure 39. Global Antibody-radionuclide Conjugates Market Size by Region (2020-2025)
Figure 40. North America Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Antibody-radionuclide Conjugates Sales Market Share by Country in 2024
Figure 43. North America Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Antibody-radionuclide Conjugates Market Size by Country in 2024
Figure 45. U.S. Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Antibody-radionuclide Conjugates Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Antibody-radionuclide Conjugates Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Antibody-radionuclide Conjugates Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Antibody-radionuclide Conjugates Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Antibody-radionuclide Conjugates Sales Market Share by Country in 2024
Figure 53. Europe Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Antibody-radionuclide Conjugates Market Size by Country in 2024
Figure 55. Germany Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Antibody-radionuclide Conjugates Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Antibody-radionuclide Conjugates Sales Market Share by Region in 2024
Figure 67. Asia Pacific Antibody-radionuclide Conjugates Market Size by Region in 2024
Figure 68. China Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Antibody-radionuclide Conjugates Sales and Growth Rate (K MT)
Figure 79. South America Antibody-radionuclide Conjugates Sales Market Share by Country in 2024
Figure 80. South America Antibody-radionuclide Conjugates Market Size and Growth Rate (M USD)
Figure 81. South America Antibody-radionuclide Conjugates Market Size by Country in 2024
Figure 82. Brazil Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Antibody-radionuclide Conjugates Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Antibody-radionuclide Conjugates Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Antibody-radionuclide Conjugates Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Antibody-radionuclide Conjugates Market Size by Region in 2024
Figure 92. Saudi Arabia Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Antibody-radionuclide Conjugates Production Market Share by Region (2020-2025)
Figure 103. North America Antibody-radionuclide Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Antibody-radionuclide Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Antibody-radionuclide Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 106. China Antibody-radionuclide Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Antibody-radionuclide Conjugates Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Antibody-radionuclide Conjugates Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Antibody-radionuclide Conjugates Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Antibody-radionuclide Conjugates Market Share Forecast by Type (2026-2035)
Figure 111. Global Antibody-radionuclide Conjugates Sales Forecast by Application (2026-2035)
Figure 112. Global Antibody-radionuclide Conjugates Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Antibody-radionuclide Conjugates
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antibody-radionuclide Conjugates Market Size (M USD), 2025-2035
Figure 5. Global Antibody-radionuclide Conjugates Market Size (M USD) (2020-2035)
Figure 6. Global Antibody-radionuclide Conjugates Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antibody-radionuclide Conjugates Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Antibody-radionuclide Conjugates Product Life Cycle
Figure 13. Antibody-radionuclide Conjugates Sales Share by Manufacturers in 2025
Figure 14. Global Antibody-radionuclide Conjugates Revenue Share by Manufacturers in 2025
Figure 15. Antibody-radionuclide Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Antibody-radionuclide Conjugates Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Antibody-radionuclide Conjugates Revenue in 2025
Figure 18. Industry Chain Map of Antibody-radionuclide Conjugates
Figure 19. Global Antibody-radionuclide Conjugates Market PEST Analysis
Figure 20. Global Antibody-radionuclide Conjugates Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Antibody-radionuclide Conjugates Market Share by Type
Figure 27. Sales Market Share of Antibody-radionuclide Conjugates by Type (2020-2025)
Figure 28. Sales Market Share of Antibody-radionuclide Conjugates by Type in 2025
Figure 29. Market Share of Antibody-radionuclide Conjugates by Type (2020-2025)
Figure 30. Market Share of Antibody-radionuclide Conjugates by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Antibody-radionuclide Conjugates Market Share by Application
Figure 33. Global Antibody-radionuclide Conjugates Sales Market Share by Application (2020-2025)
Figure 34. Global Antibody-radionuclide Conjugates Sales Market Share by Application in 2025
Figure 35. Global Antibody-radionuclide Conjugates Market Share by Application (2020-2025)
Figure 36. Global Antibody-radionuclide Conjugates Market Share by Application in 2025
Figure 37. Global Antibody-radionuclide Conjugates Sales Growth Rate by Application (2020-2025)
Figure 38. Global Antibody-radionuclide Conjugates Sales Market Share by Region (2020-2025)
Figure 39. Global Antibody-radionuclide Conjugates Market Size by Region (2020-2025)
Figure 40. North America Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Antibody-radionuclide Conjugates Sales Market Share by Country in 2024
Figure 43. North America Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Antibody-radionuclide Conjugates Market Size by Country in 2024
Figure 45. U.S. Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Antibody-radionuclide Conjugates Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Antibody-radionuclide Conjugates Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Antibody-radionuclide Conjugates Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Antibody-radionuclide Conjugates Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Antibody-radionuclide Conjugates Sales Market Share by Country in 2024
Figure 53. Europe Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Antibody-radionuclide Conjugates Market Size by Country in 2024
Figure 55. Germany Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Antibody-radionuclide Conjugates Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Antibody-radionuclide Conjugates Sales Market Share by Region in 2024
Figure 67. Asia Pacific Antibody-radionuclide Conjugates Market Size by Region in 2024
Figure 68. China Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Antibody-radionuclide Conjugates Sales and Growth Rate (K MT)
Figure 79. South America Antibody-radionuclide Conjugates Sales Market Share by Country in 2024
Figure 80. South America Antibody-radionuclide Conjugates Market Size and Growth Rate (M USD)
Figure 81. South America Antibody-radionuclide Conjugates Market Size by Country in 2024
Figure 82. Brazil Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Antibody-radionuclide Conjugates Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Antibody-radionuclide Conjugates Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Antibody-radionuclide Conjugates Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Antibody-radionuclide Conjugates Market Size by Region in 2024
Figure 92. Saudi Arabia Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Antibody-radionuclide Conjugates Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Antibody-radionuclide Conjugates Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Antibody-radionuclide Conjugates Production Market Share by Region (2020-2025)
Figure 103. North America Antibody-radionuclide Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Antibody-radionuclide Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Antibody-radionuclide Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 106. China Antibody-radionuclide Conjugates Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Antibody-radionuclide Conjugates Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Antibody-radionuclide Conjugates Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Antibody-radionuclide Conjugates Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Antibody-radionuclide Conjugates Market Share Forecast by Type (2026-2035)
Figure 111. Global Antibody-radionuclide Conjugates Sales Forecast by Application (2026-2035)
Figure 112. Global Antibody-radionuclide Conjugates Market Share Forecast by Application (2026-2035)
